Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Notes Payables: 2014-2017

Historic Notes Payables for BIO-TECHNE (TECH) over the last 3 years, with Mar 2017 value amounting to $14.6 million.

  • BIO-TECHNE's Notes Payables rose 282.83% to $14.6 million in Q1 2017 from the same period last year, while for Mar 2017 it was $14.6 million, marking a year-over-year increase of 282.83%. This contributed to the annual value of $3.8 million for FY2016, which is 6.59% down from last year.
  • As of Q1 2017, BIO-TECHNE's Notes Payables stood at $14.6 million, which was up 305.51% from $3.6 million recorded in Q4 2016.
  • Over the past 5 years, BIO-TECHNE's Notes Payables peaked at $14.6 million during Q1 2017, and registered a low of $3.0 million during Q1 2015.
  • For the 3-year period, BIO-TECHNE's Notes Payables averaged around $4.9 million, with its median value being $3.8 million (2015).
  • Per our database at Business Quant, BIO-TECHNE's Notes Payables crashed by 36.67% in 2015 and then spiked by 282.83% in 2017.
  • Over the past 4 years, BIO-TECHNE's Notes Payables (Quarterly) stood at $6.0 million in 2014, then tumbled by 36.67% to $3.8 million in 2015, then fell by 5.12% to $3.6 million in 2016, then skyrocketed by 282.83% to $14.6 million in 2017.
  • Its Notes Payables was $14.6 million in Q1 2017, compared to $3.6 million in Q4 2016 and $3.7 million in Q3 2016.